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Learning objectives After completing this course the attendants should be: 
• acquainted with the dimensions of the overall CVD problem; 
• acquainted with the epidemiological methods and surveillance 
of CVD;
• capable for creative thinking for new approaches and 
programmes for CVD prevention and care improvement in 
their environment; 
• coordinate market-oriented strategies and activities with the 
Health For All ideologies; 
• teaching new highly effective and inexpensive methods i.e.: 
self-control, self-management, home therapies of chronically ill 
and	difficult	patients,	teams,	volunteers,	family,	neighbours;	
• inventing activities and programmes for strengthening 
intersectorial cooperation and cooperation with the 
Government; 
• able to manage activities at PHC level for CVD prevention;
• acquainted with the new technologies in CVD: diagnosis, 
treatments, trends, imaging, invasive, surgery, genetic, 
molecular epidemiology, self-regulation of risk factors;
• envisioning the future: new methods in teaching, information 
diffusion, mass detection and diagnosis of CVD, decreasing 
the costs and the mortality, prolonging the life and improving 
the quality of life. 
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Abstract The CVD (heart disease and stroke, atherosclerosis, high blood 
pressure) today are the cause of the greatest public health pandemic 
globally in the history of the world ever, with very high morbidity 
and death rate, and economical and social consequences. CVD are 
the number one killer and cause more than 50% of all deaths. CVD 
are a major cause of disability, health and human suffering. Social 
and economic losses are high and CVD cause 25-30% of all medical 
expenses. 
The risk factors for CVD are well known and largely preventable 
through health education and health promotion. The medical 
knowledge for effective prevention is available and health promotion 
programmes for prevention of CVD have a huge public health potential 
leading to increased productivity among the working age population, 
to improved functional capacity among elderly, to diminishing health 
inequalities, to a reduced needs for health and social services, and to 
an increased quality of life to everybody. 
The resources needed for CVD prevention and heart health promotion 
are modest in relation to the huge health service costs to society caused 
by CVD. There is a marked divergence between the advances in the 
expensive clinical medicine management and the much lower costs 
for prevention of the CVD. The output is a condensed informative, 
educative and action programme encompassing the following aspects 
of the CVD: epidemiology, social medicine, economics, information, 
clinical aspects, quantization, “home medicine”, research, and the 
future. 
There	 is	 a	 significant	weakness	 and	 under-motivation	 of	 the	CVD	
prevention in many countries. The action for CVD prevention 
should be comprehensive encompassing health education and health 
promotion activities toward healthy life styles, capacity building 
and strengthening, monitoring and evaluation of the policy and 
programme interventions impact, advancing public health policy, and 
engaging relevant stakeholders and sectors in partnerships in order to 
reverse the CVD epidemic.
Teaching methods 1.	A	modular	 approach:	 ten	modules	with	 appropriate	 and	flexible	
sub-modules are as follows:
• epidemiology of the CVD;
• social aspects and economics of the CVD;
•	 financing	and	other	resource	finding	for	the	CVD;
• elementary clinical aspects;
• prevention;
• “home medicine” related to the CVD;
• future: science, technologies, strategies, optimizations.
2. For the practical action programme, one or more modules could be 
chosen. It will be performed in individual or small group basis. 
3. Accessories: For the purpose of the education, the following 
facilities will be used: medical and nursing schools, clinical 
centres, public health schools, hospices, libraries, personal 
computers, additional written materials, etc.
4. The programme is designed for postgraduate students and 
professionals in: medicine, public health, health management, 
health	administration,	other	interested	profiles.
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Specific recommendations
for teachers
1. Interactive modes of teaching are preferable. Students should 
take part in the teaching. 
2. All modern technologies should be applied, but also terrain 
discussions will be practiced thoroughly. Constructive and 
heuristic improvisations are welcome. 
3.	 Two	 groups	 of	 attendants	 should	 be	 identified	 by	 the	 basic	
approach and responsibility: Public health and clinical practice 
providers. 
Assessment of 
Students
1. Very quick tests will be designed before and after the sessions.
2. Students might design questions as well (desirable).
3. The assessment should give an esteem of general knowledge, 
special subject knowledge, teaching abilities, propagandistic 
abilities, creativeness (innovativeness in new methods), practical 
abilities, enthusiasm, the area of greatest interest and particular 
abilities. 
4.	The	professor	(or	a	commission)	might	decide	on	whether	a	final	
examination is needed for individual attendants. 
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CARDIOVASCULAR DISEASES PREVENTION AND CONTROL 
Samuel Sadikario, Doncho Donev, Lijana Zaletel Kragelj
Introduction
The miracle of the 20th century in the medical world has attained few outstanding, and 
we would say almost-magical effects on modifying the nature of being. Such are the basic 
solutions of the treatment and the prevention of the infectious diseases, the exponential 
decrease of children mortality, doubling of the average human life from 40 to 80 years, 
novel	surgeries,	the	DNA	structure	and	gene	manipulation,	and	inception	of	life	in	artificial	
conditions. However, it opens the door for other life-related problems and complexities to be 
solved in the future. 
There are four imminent plagues in the 21st century: 
•	 Non-communicable diseases
•	 Weather changes and other natural phenomena
•	 Poverty and other scarcities
•	 Wars
The two entities that cause the greatest problems including life threatening and unstoppable 
rise	of	the	costs	are	the	cardiovascular	and	the	malignant	diseases.	The	first	will	remain	on	
the top of the list at least in the next few decades. Cardiovascular diseases (CVD) are related 
to about half of the deaths, 80% of the burden of disease, and 10-30% of the overall health 
care costs in the world. The main factors for the increase of the frequency of the CVD are the 
arteriosclerosis, aging, the metabolic syndrome, and the lifestyle. 
Aims
There is no a single way of solving the CVD problem. Public health (PH) will certainly not 
bring	the	problem	to	the	final	solution,	but	it	is	a	fundamental	approach,	which	is	expected	to	
bring it to a considerable reduction. This chapter is a part of an advanced and ambitious course 
in	PH,	intending	to	provide	up	to	date	and	high	quality	information,	as	well	as	qualification	of	
the students in a very narrow specialized subject. The text is related to the CVD as a leading 
PH and medical problem, recognized as such from very recently. Because of its enormous 
consequences, we insist on the urgency of spreading the information related to the CVD to 
both the expert community and the general population. Therefore, the orientation of this 
course should meet the following requirements: high quality, inventiveness, information and 
action.
Historical overview of the epidemiological transition
About a hundred years ago, there has not been such an entity as epidemiology of CVD, 
or even the more distant public health (PH) of the CVD. The three historical stages of the 
epidemiological	transition	as	defined	by	Gaziano	and	Omran	(1)	are:	
1. Pestilence and famine (before 1900, expected life 35 years); 
2. The Receding pandemics (until around 1960, decrease of famine and infections, and 
increase in rheumatic and ischemic heart diseases, expected life 50 years); 
3. The Degenerative and man-made disease (until 1980, CVD, cerebrovascular diseases, 
malignancies, expected life over 60 years). There are two additional phases appearing 
in the literature: 
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4. Delayed degenerative diseases (after 1980, CVD, and cerebrovascular disease, with 
life expectance over 70 years); 
5. The epidemic of obesity and diabetes (after 2000, in the world one billion people are 
obese, and 200 millions have diabetes). 
It is actually after the 1948 period when the notion of the epidemiology of CVD has 
appeared in the major textbooks and journals, while the PH of CVD appeared very recently 
as a part of the PH of the non-communicative diseases. Presently, parts of South Asia, South 
America and Africa are at the phase one, parts of Northern Asia and Europe are at the peak of 
the third or fourth phase, while Northern America and parts of Europe are in the fourth and 
fifth	phase	(1-4).	
Modules
The achievement of the highest quality of learning (HQL) implies the following 
assumptions:	information	selectivity,	efficient	information	provision,	experience	integration,	
and	task	qualification	provision,	the	most	simple	approach	is	the	modular	system.	The	future	
editions of this manual will certainly contain “constant knowledge” (CK) and “variable 
knowledge” (VK) quantities.
The course is designed of 10 modules. 
1. CVD entities and risk factors;
2. epidemiology of the CVD;
3. the social aspects and the economics of the CVD;
4.	 resource	finding,	including	financing	of	the	CVD	prevention;
5. the private sector and the public health (PH) of the CVD;
6. prevention;
7. “home medicine” and the prevention of the CVD;
8. information and health communication;
9. CVD in the rural medicine and in the developing countries;
10. future: science, technologies, strategies, optimization and information.
Altogether, they cover a wide range of the problem, which by the nature of the subject, are 
inter-connected	between	them.	The	student	should	be	able	to	perform	a	specific	practical	task,	
and may choose one or more modules. According to a wide experience, the best approach is 
the candidates to prepare a lecture or lectures, using this manual, information research, and 
supervision. A feedback from a valuable work will provide high quality improvements of the 
mentioned VK and even the CK. Each module is divided in sub-modules. 
CVD entities and risk factors
The Public Health and the clinical aspects of the CVD are related to several entities (listed 
on table 1), which in general could be divided in two categories: atherosclerotic and non-
atherosclerotic diseases (3-5). 
Sub-modules
Sub-module A
This sub-module is a list of CVD entities. A brief listing of categories of CVD is given 
in Table 1. 
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Table 1. Categories of cardiovascular diseases (CVD).
Category
1. Coronary heart disease (CHD) including: myocardial infarction, unstable angina, stable angina, 
and sudden death syndrome (SDS); 
2. Cerebrovacular disease (CVD or stroke);
3. Peripheral vascular disease (PVD);
4. Dissection and major vessel aneurysms;
5. Diabetic angiopathies;
6. Hypertensive heart disease;
7. Heart failure (HF);
8. Cardiomyopathies;
9. Rheumatic heart disease;
10. Congenital heart disease.
Sub-module B
Second sub-module is a list of the risk factors. A brief listing of the risk factors for CVD 
is given in Table 2 (3-5): 
Table 2.	The	identified	risk	factors	for	the	CVD.
Modifiable Non-modifiable Other
Diabetes
Hyertension
Insulin resistance
Obesity
Hyperlipidemia
Smoking
Alcohol
Drug addiction
Hyper-coagulation
Stress
Physical inactivity
Depression
High altitude
Dietary habits:
    salt intake
    water hardness
    processed food
    high thyramine content
Other co-morbidities
    endocrine disease
    hyper-uricemia
    renal disease
    rheumatic disease
    vasculitis
    connective tissue disease
    trauma
    hyperviscosity syndromes
Indirect factors
    poverty, culture
    pharmaceuticals
Heredity
Age
Previous CVD events
Gender
Ethnicity
Inflammation	(markers)
   CRP
   TNF
    sICAM
    IL 6
    IL 18
Metabolic
    NO (def.production)
    D-Dimer
    Fibrinogen
    Homocystein
LEGEND: CRP = C-reactive protein; TNF = tumor necrosing factor, IL interleukin; NO = nitric oxide
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The main risk factors are aggregated in the entity of “metabolic syndrome”, including 
smoking, hypertension, diabetes, insulin resistance, obesity, hyperlipidemia and low physical 
activity.	This	needs	discussions,	experience,	classifications,	practical	work	with	physicians,	
nurses,	 patients	 and	media	 professionals.	 Introduction	 of	 quantifiers	 (Framingham	 index,	
SCORE) in everyday practice and epidemiological studies is mandatory. Lemma: any kind 
of	prevention	of	 the	CVD	and	modification	of	 the	outcome	of	 the	CVD	(disease	outputs)	
depend	on	the	modifications	of	the	risk	factors	(inputs)	(3-5).
Epidemiology
The epidemiology is both “anatomy”, “pathology” and “patho-physiology” of the 
PH. Any strategic, economic, or preventive project should be built up over a previous 
epidemiological study. In our case, it includes the epidemiology of the CVD and the risk 
factors. The mortality rates have declined in the developed countries, but in the developing 
countries, they increased or remained the same. The prevalence and the incidence rates have 
increased in all countries, which is due to the increased survival, the aging population, and 
the increase of the frequencies of most of the risk factors (3-6). 
The “discovery” of the epidemiology of the CVD is an achievement of the second half of 
the 20-th century (1,2). It started with the models of the epidemiology of some risk factors, 
i.e. diabetes, hypertension and rheumatic diseases, and it was recognized as a problem after 
noting the enormous mortality rates and the increase of the costs. The CVD today pause 
greater problem than the tuberculosis and the syphilis together in the former centuries. 
Looking at the history of medicine, until 200 years ago, less than 10% of the population 
would have died from heart diseases, with the life duration being less than 40 years. They 
have not even had the “opportunity of becoming old”. People would have mostly died either 
during the birth, or soon after that by infection, or by the consequences of wars. The tasks 
of the CVD epidemiology are the detection of occurrence, surveillance (trends of changes), 
natural history studies, etiological hypotheses (risk factors), comparisons (meta-analysis) and 
prevention programmes contribution. Those are concentrated in three categories of CVD 
epidemiology as revealed on the table 3 (3-6):
Table 3. Categories of CVD epidemiology.
Category Description
Descriptive epidemiology incidence rates, prevalence rates, mortality rates according to entity, age, sex, geographical gradient
Analytic epidemiology
estimating relationships between CVD and risk factors, 
actuarial analyzing, risk model development, meta-analyses, 
econometric analyses
Experimental epidemiology interventions: studies, prevention strategies
The sub-modules
Sub-module A
The	first	sub-module:	an	elementary	and	encyclopaedic	review	of	the	basic	epidemiological	
notions which are important for the CVD - mortality rates, prevalence rates, incidence rates, 
trends, gradients, study design, collection of data, data representation, and some simple 
mathematical modelling. It is worth noting the peculiarity that very simple mathematical 
concepts	 pause	 rather	 difficult	 performances	 in	 the	 practical	 executions,	 such	 are	 finding	
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prevalence rates, incidence rates, mortality rates and avoiding biases. Why? The student 
should be acquainted with as many biases as possible, since they are so massively present in 
the clinical studies, population research, and the dissertations. This is particularly the case 
in the developing countries, where public health institutions are either at their inception, or 
do not exist at all. Very serious research works have been harmed by various biases, which 
is	followed	by	inevitable	financial	losses.	Even	the	meta-analyses	when	non-including	data	
from underdeveloped countries or regions could be considered as “damaged” or biased. There 
are two possible remedies for those problems: 
1.	 The	first	level	solution	is	obligatory	consultation	of	an	epidemiologist	or	at	least	a	qualified	
medical statistician for each CVD study. 
2. The second level solution is as we propose: a networking of public health schools (PHSN), 
which	would	enable	high	 level	of	 information	flow,	high	 level	of	quality	control,	 real	
validity	of	the	information,	reducing	expenditures,	and	international	affirmation	of	each	
valid research work from any medical centre. 
Sub-module B
The	second	sub-module:	real	figures.	50-60%	of	all	deaths	in	the	world	are	due	to	CVD	
(3-6). 
1. The coronary heart disease. 
In the US 1.680.000 persons are reported annually with ACS (acute coronary syndrome), 
1.5 million/y with myocardial infarction (MI), which is 600/100.000/y. There are 500.000-
700.000 deaths/y in the US. In the world there are 12 million deaths from MI per year, and 
that is 50% of all deaths. One third of the STEMI (ST elevation myocardial infarction) 
die	within	the	first	24h,	and	more	than	half	of	those	deaths	are	in	the	pre-hospital	phase.	
In	 hospital	 deaths	 from	STEMI	 are	 10%,	 and	 another	 10%	 during	 the	 first	 year.	The	
factors	to	prevent	those	still	high	mortality	figures	include:	transportation,	and	risk	factor	
modifications	 (hypertension,	 hyperglycemia,	 hyperlipidemia,	 hypercoagulation	 and	
smoking). Age: most of the cases are before the age of 45, and more in males until 70. 
The pre-45 MI incidence is increasing, with the main risk factors being the cocaine use, 
diabetes, renal disease, hyper-cholesterolemia, and family clustering. The infant death 
rate from MI is < 0.2 / 100.000/y for one year old or less, and 0.2/100.000/y for 15-24 year 
old. Age, sex and heredity explain approximately 50% of the deaths. Generally, angina 
pectoris is more frequent in females, while MI in males. MI frequency and prognosis 
worsens in the postmenopausal period. Unregulated diabetes increase the death rate by 
30%. Each 10 mmHg increase of blood pressure above normal (130/80) double the risk 
of coronary heart disease. 
2. Stroke. 
In	the	US	500.000	cases	per	year	have	the	first	time	stroke.	It	is	estimated	to	increase	to	1	
million by the 2050. About four million people (4.3 million in 1990) die from stroke per 
year in the world. In the US stroke accounts 7.1% of all deaths. The incidence is higher 
in males, mainly over 65. However, 25% of the cases occur before 65. It is estimated that 
before the age of 70, 1 in 20 persons will suffer a stroke. A sharp decline of mortality 
rates	 were	 registered	 between	 1972	 and	 1980,	 which	 reflects	 improved	 diagnostic	
criteria and facilities, and the increased awareness. The main risk factors include: age, 
hypertension,	 smoking,	heart	disease	 (atrial	fibrillation,	MI),	diabetes,	hyperlipidemia,	
and oral contraceptive use (especially in smokers). 
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The socio-economics of the CVD
If you want to do something for your country, do something for the social medicine. 
This expresses the importance of the social medicine in modern life. There is a diversity of 
opinions	on	whether	the	socioeconomic	status	(SES)	influence	on	the	outcome	of	the	CVD	
is a “direct” or “indirect” factor or complex of factors (7-9). It is unanimously accepted that 
there is a correlation between the SES and both the incidence and the mortality of the CVD. 
The “rule of 3’s” is as follows: one third of the population does not feel healthy; the poor 
population feels ill three times more frequently than the wealthy and the educated; the poor 
are three times more frequent than the wealthy in the developed countries; the three levels of 
SES consist of: material, behavioural and psychological status. 
In-deep	evaluation	of	the	SES,	including	quantification	originates	from	very	recent	dates	
with the important works of Kunst, Mackenbach and Regidor (10-12). Inequalities in health 
care make a very sensitive and painful issue in the developed countries. They are found 
to	 influence	 strongly	 the	 incidence	 and	 the	 outcome	 of	CVD.	 In	 the	 next	 few	decades	 it	
will be very important to develop further the quantitative instruments for measuring the 
socioeconomic inequalities in a given society or state. 
Lemma:	 It	 is	more	 beneficial	 to	 engage	 or	 educate	 the	 local	 intellectual	 resources	 in	
planning and organizing the social medical and PH programmes in your country, rather than 
engaging	foreign	experts.	The	experiences	in	the	developing	countries,	and	the	cost-benefit	
estimates reveal that in most developing countries, especially the former socialist states, have 
achieved considerable amount of high education, experience, motivation and infrastructure. 
Cultural disparities and high costs are frequently the background factors of those “tutoring” 
approach	 inappropriateness.	 The	 solution	 is	 in	 the	 more	 efficient	 and	 cost-benefit	 inter-
cultural communications (12), and improved expert communications i.e. the case of PHSN.
The sub-modules
Sub-module A
The	 parameters	 of	 the	 SES:	 defining	 and	 evaluating.	 There	 is	 considerable	 level	 of	
subjectivity	and	self-estimation	on	the	quantification	of	the	SES.	The	SES	parameters	that	
have been considered in the studies of the CVD include: the income of the patient, the income 
of the patient’s parents, the education of the patient or the parents, ethnicity, the neighbour 
context, unemployment, risk factors related to the SES – smoking, alcohol, obesity, diabetes, 
nutrition, stress, and hypertension (3-5, 10-12). 
Sub-module B
There are a variety of mathematical models and calculators of the socioeconomic status 
of a given population as determined by Kunst, Regidor, Mackenbach, Lorenz etc. (10-12). 
Those models are useful in the determining of the impact of the social strata, education, 
poverty, education of the parents, social status of the parents and other related factors, on the 
incidence and mortality of a chronic disease, in particular the CVD. It has been found that 
lower social class is more frequently associated with CVD, mortality, and the risk factors 
such are diabetes, hypertension, stress, smoking, alcohol, and hyperlipidemia. 
Resource finding financing of the cvd prevention and public health
As mentioned previously, the direct costs of the treatments of the CVD are from one 
fourth to one third of all overall health care costs (1-5). In the US the annual expenses for the 
curative CVD management are near 400 billion dollars. The US costs of diabetes mounted to 
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130 billion dollars per year. There are no data on the costs of the CVD prevention. Thus, how 
are	we	going	to	make	the	budgeting,	let	alone	the	finance	finding	of	the	CVD	prevention?	
Hoping that those needs signify the “transition period” for the overall CVD management 
(from	predominantly	“curative”	to	equally	“preventive”),	a	flexible	and	innovative	complex	
of interventions has to be undertaken (13-14). It is very important that the pursuers of this 
module and this professional orientation should have some previous knowledge in medical 
financing	 –	 best	 to	 hold	 a	 Masters	 Degree	 on	 medical	 financing,	 general	 financing,	 or	
economics. 
A highly creative approach spectrum is needed to be developed, which should create 
“symmetry” of seemingly divergent realities – market economy, health provision inequality 
gap, and rapid development with the non-linear increase of the expenses (13-14). 
The sub-modules
Sub-module A
Sub-module	A	is	a	review	of	general	financing:	
•	 consulting	 services	 (i.e.	 accounting,	 tax,	 management,	 finance	 planning,	 forensic,	
business valuation, fraud prevention and detection, litigation, and technology 
consultation), 
•	 banking basics, 
•	 stock marketing basics, 
•	 portofolio models, 
•	 derivative pricing, 
•	 option trading, 
•	 cash management, 
•	 regulatory and tax issues, and 
•	 financial	instrument	application.	
How they function in your country? Although at “encyclopaedic” level, this knowledge 
should	be	discussed	and	performed	with	the	assistance	of	financial	experts	(13).	
Sub-module B
The content of this sub-module is tackling the meaning of the prevention and the PH 
financing	(14).	There	are	three	reasons	for	medical	compulsory	insurance	of	prevention	and	
PH of the CVD: 
1. to avoid later treatments and their large bills; 
2. optimization of the prevention, and 
3. on-time detection. 
Compulsory CVD prevention is a direct investment in mortality decrease and lifespan 
increase. There is an enormous amount of offered insurance packages on the market, as 
opposed to the vast majority of uninformed individuals (including the most educated), 
which in a given situation might not meet the best condition of coverage. The increase of 
the prevention and PH related insurance on the CVD should be at least parallel to the rise 
of the health care costs, which in the developed countries is 10-15% per year. So, individual 
instructors for prevention insurance packages are needed. In the US, only 32% of the Hispanics 
have any health care insurance (including prevention), while among the white population it is 
53%, which is bellow the rates in other developed countries (14). 
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The private sector and the public health of the CVD
There is a tendency of intense growth of the private sector in the developing countries. 
Although mainly high performance “curative” oriented (15), there is a considerable tendency 
of	preventive	orientation	of	the	private	institutions.	Because	of	the	lack	of	financial	resources	
at the national levels in those countries, they are being forced to the transition from state-
managed medicine to a private medicine. Most of the private practitioners (GP, family 
doctors, internists, and paediatricians) are very much interested in CVD practice. The CVD 
investments become very high, consisting of equipment investments, and pharmaceutical 
expenses which a large portion of the overall health-related expenses. In the developing 
countries, the private sector is mostly concentrated in the outpatient centres, while in the 
developed countries a considerable portion of the in-patient institutions are in the private 
sector (15). It is conceivable that the private sector will grow in the next few decades. It 
is	 also	 a	 good	 source	 of	medical	 education	financing	 (self-financing).	Although	 the	 ideal	
mode of practices would be those related to the preventive medicine, there are still very few 
programmes and activities oriented to private-medicine-based prevention. The most probable 
reason for that is the curative-medicine-oriented education of the medical doctors and the 
nurses, as well as the high-level investments required for the CVD practice. However, the 
cost-benefit	complex	of	the	preventive	medicine	and	the	high	performance	private	sector	is	a	
noticeable opportunity of the recent future (15-16). 
The sub-modules
Sub-module A
This sub-module is about advantages and disadvantages of the private sector concerning the 
CVD. High performance private sector centres have large advantages over low performance 
centres in the quality of care and the mortality reduction (15). On the other hand, the costs in 
the high performance private centres are much higher than in the relevant state hospitals. In 
the developing countries, the private sector has the advantage in the low cost interventions, 
which might be covered even on out-of-pocket basis. Although they can be adapted for 
emergency cases, in those countries they are still better managed in the state hospitals. Home 
therapies are still under the state institution coverage, although there is a high potential for the 
private	sector.	The	private	sector	is	slow	growing	and	very	difficult	to	develop	in	very	poor	
and low income countries (i.e. less than 1000 US $ per insurance recipient per year). 
Sub-module B
Establishing the predominantly preventive CVD private centre is a challenging paradigm, 
and a requiring for the strategists. In theory, there are not such narrow-specialized private 
centres.	However,	in	the	practice	there	are	cost	benefit	units	whose	incomes	are	predominantly	
coming from CVD patients. Regarding the aging population rise and the high frequency 
of the risk factors, as well as the high frequency of post-event patients, there is a need of 
such centres – either strictly specialized, or at least 50% engaged with CVD patients. Good 
examples of specialized centres (both private and state-owned) are the diabetes centres, 
hypertension clinics, neurological centres (stroke) etc. Prepare a concept of a specialized 
private CVD prevention clinic. 
Sub-module C
This sub-module is about the position of the nurse in CVD prevention, especially in the 
preventive private sector. 
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The nurse can be engaged individually or in a team in the preventive CVD programmes 
on private basis. A very good example is the experience the cases on home preventive care. 
The specially educated nurses can perform screening, control and education related to the risk 
factors (i.e. smoking, diabetes, obesity, hyperlipidemia, hypertension, exercising, screening 
and CVD detection, etc). In rural environments, or quarters with poor people, nursing might 
be the only cost-approvable or affordable PH providers. 
Prevention of the CVD
This	 is	a	very	difficult	 subject.	Why?	The	answer	 to	 the	question	why	 is,	because	 the	
plethora	of	the	questions	which	are	fundamental,	and	the	answers	which	are	superficial.	Few	
of those questions are: 
•	 How	to	improve	the	finances	(they	are	not	even	at	the	starting	point	in	most	of	the	
countries); 
•	 How	to	find	final	solutions	(such	as	the	example	of	the	smallpox	and	other	infective	
diseases); 
•	 If the consequences and the aim of the CVD prevention are to prolong the life of 
the population, how are we going to deal with the problem of the aging population 
(without ideas of restructuring the society, with no paradigms both individual or 
collective for the increasing mass of that population which tends to become the half 
of the world in the next decades); 
•	 How to integrate the leading clinical minds in the public health community (the great 
majority of the medical intellectual capacities are concentrated in the clinical wards, 
challenged	by	the	rapid	advances	in	the	field	of	the	clinical	medicine)	(2-5,	17-20).	
The goals of the CVD prevention are to decrease the incidence and the mortality from 
those entities as revealed on table 4 (3, 4, 17, 19): 
Table 4. The goals of the CVD prevention at all levels.
Level of prevention Tasks/activities
Primordial Social
Legal, ethical, human rights
Economic
Cultural, social marketing etc.
Primary Risk factor control i.e.
•	 education;
•	 counselling (diabetes, hypertension, diet etc);
•	 check ups (risk populations, women, professions);
•	 treatments (diabetes, hyperlipidemia, alcoholism etc.).
Secondary Symptomatic patients: 
•	 screening, detection;
•	 proper treatment (proper medicaments);
•	 risk factor elimination (rigorous);
•	 regular control;
•	 invasive and operative approach (if indicated);
•	 self-control and home therapies.
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Prevention should mean adding ages to healthy organisms and minds. Prevention of the 
CVD is not a the domain of medical doctors only, but it is a structure made up of almost all 
profiles	of	professionals	and	researchers	dealing	with	the	most	fundamental	laws	of	nature	
and the laws of society. The approach in all levels can be: individual, collective, and mass 
(i.e. social marketing, media, schools, regulative). Few examples of community-wide CVD 
prevention programmes are given on the table 5: 
Table 5. Community based programmes – examples
Community based programmes
1. Framingham Heart Study (1948-). USA. Framingham risk scoring
2. Stanford Project (1972-5, 1980-6). USA
3. Minnesota Cardiovascular Health Programme (1980-8). USA
4. Multiple Risk Factor Intervention Trial (1972-9). USA
5. North Karelia Project (1972-). Finland
Sub-modules
Sub-module A
This sub-module is dealing with the atherosclerosis, the risk factors and the metabolic 
syndrome. Atherosclerosis is a complex biological process leading to arterial wall thickening 
of the large and moderate muscular arteries, leading to haemodynamic and oxygenation 
insufficiencies	of	the	peripheral	tissues	(heart,	brain,	extremities,	kidneys,	etc),	ending	with	
tissue	and	organ	insufficiencies	and	death	(3-4).	At	the	turn	of	the	20-th	century,	the	Russian	
researchers (Anitschow, Ignjatovski, Chalatow, Sarkisov) showed that cholesterol fed rabbits 
increase	the	rate	of	atherosclerosis,	but	it	was	not	until	the	fifties	that	recognition	was	given	
to	the	“possibility”	of	hyperlipidemia	associated	with	atherosclerosis.	The	first	classification	
of	 the	hyperlipidemias	appeared	as	defined	by	Fredrickson	in	1956.	Then	the	Nobel	Prize	
in	 the	 field	 was	 awarded	 to	 Bloch	 and	 Lynen	 (1964),	 and	 Brown	 and	 Goldstein	 (1985)	
(18)	for	the	lipid	metabolism	research	and	the	atherosclerosis.	In	1976	for	the	first	time	the	
cholesterol was proved as being an “independent factor” for atheromatosis, and in 1980’s 
appeared	the	first	intervention	study	showing	that	pharmacological	lowering	of	cholesterol	
leads	to	significant	decrease	of	the	CVD	incidence,	while	in	1988	appeared	the	first	detailed	
description of the chemistry and physiology of the “statins” (HMG-Co A reductase inhibitors) 
(1-2). This was important for the conclusion that interventions are important factors in all 
phases of prevention of the CVD. Then followed the phase of the “good cholesterol” and 
the “bad cholesterol in the 1990’s, reacting with the haemostatic complexities, followed 
by	 the	era	of	 infection,	 inflammation,	cytokines,	and	 inflammation	markers	 in	 the	2000’s,	
which	continues	now	entangled	with	the	research	findings	on	genetic	markers,	mechanical	
factors, nitric oxide production/inhibition, endothelial hormone interactions, and the insulin 
resistance. Those factors are of utter importance to understand the directions of the present 
and the future preventive interventions. Then followed a spectrum of multi-centre clinical 
and intervention studies, which the involved student will have to investigate and analyze. 
Mathematical models and quantitative approach have been experimented recently, based on 
epidemiological and longitudinal data. Introducing mathematical models in clinical practice 
is	 a	 slow	process,	 but	 simplification	will	 lead	 to	very	useful	quantitative	 tools.	However,	
equation parameters might vary between populations, due to geographical, genetic and other 
gradients, therefore adjustments become a necessity (1-6, 17-20). 
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Sub-module B
This sub-module is on the levels of prevention. At the beginning there was a “simple” 
division of primary and secondary prevention, according to actions undertaken in the “pre-
event” (before MI or stroke), or “post-event” (after MI or stroke) periods. However, in such 
oversimplification	few	very	basic	questions	arise	i.e.:
•	 If diabetes is MI-equivalent, then the prevention is primary or secondary in all 
diabetics;
•	 When is the period when the “primary” prevention should start;
•	 Is it ethical not to give the same advice to the “primary” case as to the “secondary” 
one, even if he/she is at mild risk? Recently, all CVD events have been considered for 
“secondary” prevention (3-4, 9, 19, 22); 
•	 What about the non-event case at high risk (using calculator or SCORE systems, or 
assumption on heredity basis, or even empirical). 
Thus, some universal model is needed. The student should collect the data from all recent 
major studies, as well as the guidelines, and make a report. The preventive interventions can 
be divided in three groups: 
1. Behavioural: diets, exercise, ceasing smoking, alcohol, and regimes for eliminating the 
controllable risk factors; those are safely recommended for all who are at any risk, or even 
to the “non-risk-period”; children with risk factors are also included; 
2. Pharmacological: regulation of hypertension, hyperlipidemia, hyperglycemia, 
antiaggregation – for all who are at high risk and/or post-event, and selected cases that 
cannot achieve the target values of the risk factors with the measures under point 1; 
3. Invasive and surgical interventions: in high-risk pre-event and post-event cases, according 
to	the	specific	guidelines	and	the	decisions	of	the	cardiology	specialists.	
Up-to date levels of target values of the risk factor indicators at the present time are given 
in table 6 (3-4): 
Table 6. Risk factors target values.
Risk factor Target value
Smoking 0
Blood pressure 120/80 mmHg
LDL <2.5 mmol/l (<1.5 after CVD event)
Total cholesterol <4.5 mmol/l
Triglycerides <1.1 mmol/l
HDL >1.1 mmol/l
HbA1c <6.5 %
Glycemia (IDF)
 Fasting <6.5 (100 mg%)
 2h postprandial <7.2 (135 mg%)
CRP <0.6
BMI 25-29.9 kg/m²
Abdominal circumference
 Europoid <94 cm (males) <80 cm (females)
 South Asian <90  <80
 Chinese <90  <80
 Japanese <85  <90
     Source: American Heart Association, 2004
Sub-module C
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This sub-module is about assessment of cardiovascular risk using “calculators”. The 
most	 popular	 simple	 quantifiers	 of	 the	 outcome	 in	 CVD	 are	 the	 Framingham	 calculator	
and the SCORE (3-4). Although they are recommended as routine procedures in all general 
practitioners’ and relevant specialist outpatients, they are still not a routine, at least in the 
developing countries. On the other hand, there are some recent critics of certain inaccuracies, 
and	 inconsistencies	of	 those	systems,	 therefore	modifications	or	new	quantifiers	are	 to	be	
expected in near future. A practical work with those calculators is recommended to the 
candidates, on real or simulated cases as recommended by the supervisor. 
Sub-module D
This sub-module is about childhood, adolescence and CVD (3, 4, 17, 19, 22). There was 
an increase of obesity, hyperlipidemia, and diabetes in children and adolescents in the last 
decades, both in the developed and the developing countries. The obesity prevalence rates 
mounted up to 14% of the children. The hyperlipidemias are mostly multigenic, risk factor 
associated, and secondary. Primary prevention measures are necessary in this population. 
Sub-module E
This sub-module is about public health actions in prevention of the CVD (3-6, 17-22). 
Develop a community based CVD primary prevention plan. Develop screening programmes 
for all individuals over the age of 40, and for the vulnerable populations - elderly, rural, 
poor, post-menopausal women, diabetics, patients on chronic dialysis, and drug addicts. 
Despite	the	well-known	and	well	defined	problems	related	to	CVD,	and	the	recent	preventive	
guidelines, the efforts remain more on the theoretical ground. The practical problems stem 
mainly	from	the	following	factors:	insufficient	awareness	both	in	the	population	and	among	
the	authorities,	conflict	of	interests	(i.e.	food	and	cigarette	industries),	and	the	financing	of	
prevention problems as mentioned above. The SES, the social and the cultural differences 
play a considerable direct and indirect role. The few suggested short-term improvements for 
the PH ground are related to the rise of the population and the professional awareness i.e.: 
1. education of the health professionals, special for-credit and non-for-credit curricula in the 
medical, PH and nursing schools; 
2. education of the population (mass media, persistent health communication, courses, 
volunteer educators, school programmes); 
3. education of the patients: thorough insisting on behavioural and pharmacologic therapies; 
self-control and regular check ups in chronically ill and those at high risk should be 
conducted intensely; 
4. continuous improvement of the prevention – control of the measures, and creative 
approaches; 
5. PH institutions should insist on governmental and other resource funding of periodic 
minimal examination of schoolchildren, young people, and the risk populations on 
mandatory basis. 
Prevention of the CVD is a duty of the whole population (individually and collectively) – 
viewed the same as the elementary education or the personal and communal hygiene. Which 
are the measures that you are going to undertake in your country for the improvement of the 
CVD prevention? 
543
Cardiovascular Diseases Prevention and Control
Sub-module F
This sub-module is about private sector and prevention of the CVD (15). Orientation 
on prevention is of great interest for the private practitioners, to turn to low-expense highly 
profitable	 practice,	 consisting	on	 the	 above	mentioned	measures	 related	 to	 the	 education,	
control, and follow up of both healthy population, risk population and the chronically ill. 
Private-based annual group check-ups (companies, regions) in a form of “un-expensive 
packets” for CVD and malignancy screening, appears a feasible, high cost-utility, and a 
profitable	business.	Make	your	innovative	project	on	improvement	of	the	prevention	on	cost-
effective private practice based system. 
Sub-module G
This sub-module is about nursing and prevention of the CVD. High performance nursing 
is	an	ideal	opportunity	for	cost-benefit	promotion	of	the	CVD	prevention	(16).	With	special	
curricula and training, nursing had already become a major factor in the above-mentioned 
goals of the CVD prevention. High performance and low-to-moderate cost nursing home 
therapies are feasible and affordable for the mass of the middle class population. It appeared 
feasible also for the poor people in the cases of charity organizations and trusts support (i.e. 
Caritas, Hope, Sue Ryder Care, Lady Fatemah Trust etc.). 
“Home medicine” and the prevention of the CVD
“Home medicine” has emerged not as a product of science, but rather as a derivate of a 
necessity and the health care pragmatism (23). In a presently empirical basis, we state that 
the “home medicine” is the best mode, possibly the unique one, to achieve lowering of the 
costs to the supportable level, in a setting of high performance in both preventive and curative 
medicine. Of course – a lot of work has to be done. 
Lemma: the experiences of the success in the home treatments and preventive measures 
on individuals can be extended to populations. 
This maximum should be expanded continually. This does not represent an idealism, but 
rather a very real necessity (23). In the underdeveloped and the developing countries, there 
is a “culture” of institutional (hospital) detection and treatments of all patients, including 
the	screening	of	 the	healthy	population.	It	was	a	specific	paradigm	in	 the	former	socialist	
countries, regarding the health system as an instrument and morphology of communism. 
That brought to enormous unnecessary expenses to the weak health care budgets of those 
countries, which consequences resulted in reduced-resource practice, decline in the quality of 
medicine,	impossibility	of	mass	prevention,	and	a	significant	fall	of	the	economical	status	of	
the doctors and the medical staff. “Home medicine” existed in the Middle Ages both for the 
high class, and the rural middle class, while institutions were rather “isolation formations” 
or later army institutions. They have grown in France in the post-revolution period, as a 
part of the simultaneous growth of the civil-right system and the diagnostic medicine, while 
preventive medicine (institutional only) came on the stage much later. In contemporary 
times,	 the	medical	 institutions	are	 fortifications	of	 the	huge	 technological	machinery,	 and	
the advances of the operative medicine, and there is an increasing feed-forward mechanism 
of technology proliferation stimulated expensive medicine. Home prevention oriented less 
expensive technologies are the forthcoming counterpart emerging slowly but surely. Again, 
the	accumulation	of	unrealizable	financial	gaps,	the	insufficient	infrastructure	effectiveness,	
and the increased prevention awareness are the stimulating factors for “home medicine” and 
prevention expansion. 
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In each family, there is at least one old person, or one who has a CVD related problem. 
Thus, medicine is in your home. Unwillingly you are a “home medicine” performer. 
Sub-modules
Sub-module A
Make	an	elaborate	of	the	needs	and	the	cost-benefit	of	the	transition	from	institutional	to	
“home medicine” in your country. 
Sub-module B
This sub-module is about description of the successful existing modes of home therapies 
in cases of: diabetes, hypertension, stable angina, rehabilitation therapies, post-stroke patients 
etc. 
Sub-module C
This sub-module is about self-control and safe treatment experiences, as the fundamental 
basis of home therapies. Case studies of elaborate examples. 
Sub-module D
This sub-module is about nursing. There are two modes of home nursing: a complementary 
care to the chronic therapy programme, 
Sub-module E
This sub-module is about Paradigms of home prevention programmes introduced by 
family doctors, general practitioners, nurses, patients and volunteers. There is an increasing 
interest of the healthy risk population (patient’s families, surrounding, and well-informed 
individuals) for individual screening, with a tendency of preferring home laboratories 
(mobile) to the institutional ones. 
Sub-module F
This sub-module is about Partial transforming of the institutional outpatient’s departments 
to private communal centres or home prevention and treatment medical groups (nurses, or 
even educated volunteers). The home prevention paradigm (HPP) is a key for affordable and 
profitable	market	oriented	prevention	of	 the	CVD.	The	HPP	 is	a	complex	 transformation,	
which includes: 
1. Increasing the “culture” of the population for the home prevention and follow up (self-
control, self-care, technological and medical culture, interaction with doctors, media, 
schools, religion, social marketing, nursing, volunteering, patient-to-patient and patient-
to-family information and help, prevention oriented associations etc); 
2. Achieving high performance home activities: institution-home interactions (emerging 
preventive packages contracts, including the private sector), teaching self-management 
and self-screening, community aid, family aid, home practitioners (nurses, doctors, 
defectologists, versatile volunteers), and special prevention services development (23). 
Changing markets means comforting human needs – home based detection and therapies will 
follow the fate of the microchip – it will open a huge and demanding market. Think of the 
transformation from patient associations to patient corporations. 
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Information and health communication 
This	is	also	an	important	(24),	yet	insufficiently	exploited	tool	of	CVD	prevention.	In	our	
experience,	just	few	TV	popular	programmes	had	caused	a	significant	interest	and	clinical	
visits of patients with CVD, hypertension and diabetes. The prevalence of detected diabetes 
is doubled when considering the “unknown” cases. Which are the frequencies of the “silent” 
CVD events? Which are the frequencies of the “known” CVD events, who do not or cannot 
take	appropriate	care	of	their	disorder?	How	much	the	environment	influences	the	increase	of	
the morbidity and the mortality from the CVD? Those are not problems, which can be solved 
by the medical practitioners only, but rather by the joint actions of the entire population. 
Education is high performance information processing, institutionally controlled, quality 
controlled,	 with	 feedback	 information	 return.	 It	 is	 certainly	 the	 most	 efficient	 mode	 of	
information delivery, however its weak sides are the always the limited number of recipients 
and the cost containment. Multi-level CVD education programmes are required, to promote 
the	growth	of	qualified	educators	from	community	to	highly	specialized	levels.	The	experts	
and the expert institutions of CVD are the “think tanks” of the education, information, 
management and prevention strategies.
What is the difference between information and health communication? Information 
only cannot change conviction and behaviour. Health communication is a systematic change 
of perceptions (individual and collective), causing action (24). Propaganda is “information 
times	motivation”.	Artificially	we	can	distinguish	three	levels	of	information	processing	for	
the purpose of medicine: 
1. Education: a programmed training of professionals or patients and amateurs in performing 
medical manipulations or assistance; a feedback from each individual is evaluated; this is 
for a limited number of individuals. 
2. Information: denotes providing facts to a larger population, expecting a positive effect, 
but without any systematic control of the effects. 
3.	 Health	 communication:	 increased	 efficiency	 of	 the	 information,	 using	 technologies	
that can increase the number of the informed individuals and their positive reaction. 
Health communication is “information quantity” multiplied by “diffusion force”. The 
“aggressive”	media	 programmes	 have	 influenced	 the	 epidemics	 of	 the	HIV	 infection,	
and the information system networks were the critical factor of it’s discovery. They 
have	 certainly	 influenced	 the	 awareness	of	 the	 risk	 factors	 i.e.	 diabetes,	 hypertension,	
hyperlipidemia, and smoking. 
Mass media are instruments of the politically active groups. Thus the rate of media 
development is proportional to the political group dynamics. Lemma: media development in 
health	means	influence	of	the	medicine	on	politics	and	vice	versa.	Information	flow	multiplied	
by health equals health policy multiplied by economics. 
Sub-modules
Sub-module A
This sub-module represents an introduction to the module: elementary knowledge on 
CVD, socio-medical aspects, and prevention of the CVD, from the previous modules. 
Sub-module B
This sub-module is an introduction to a medical journalism and information: public 
relations foundations, the news media and the CVD, the “power” of prevention, the need of 
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early detection, specialized reporting (research, conferences, economic aspects), strengthening 
health journalism in the developing countries, training journalism to cover news and reports 
on CVD subjects, analysis of media covering, improving reporting, the global impact of the 
CVD reporting, public relations theory and practice, gaining audience, database and web 
research, writing, reporting, and psychology of communication (24-25). 
Sub-module C
This sub-module is about mass communication ethics (24-25): law in mass communication 
and journalism (legal research, critical reading, question generating), elements of ethics in 
journalism (consequences, norms, changing life of the readers), management in journalism, 
Nuremberg Process (Boston university curriculum in PH).
Sub-module D
This sub-module is about social-marketing impact on the masses. Session are prepared 
on the following topics: 
1.	 How	the	health	communication	has	succeeded	to	influence	the	smoking	reduction	in	the	
developed countries;
2. Why it failed in the developing countries;
3. Social marketing process planning related to the CVD for the next decade.
Sub-module E
This sub-module is about how to use the Public Health School Network (PHSN) to spread 
the information, and to receive information. PHSN is an ideal structure for information gain 
and information spreading. Students are supposed to learn to establish a collaboration relation, 
and learn to use the most recent telecommunication systems and software. 
Sub-module F
This sub-module is about health communication in elementary and secondary schools: 
• how to organize health communication (e.g. health education) process, 
• how to overcome the children disinterest on “serious” themes (use the positive and 
negative experiences from similar programmes), 
• how to select the topics, 
• how to prepare programmes and practical work,
• how to build a prevention culture. 
Sub-module G
This	sub-module	is	about	new	models	of	information	design	and	information	flow.	
Rural medicine and CVD prevention 
Rural medicine is a relatively novel programme of an old profession (26). It is based on the 
recognition of the medical provision “gap” between the developed and the underdeveloped 
areas, either between the countries, or within the countries. The “objective” reasons for 
that “gap” is expected to cause increase in the incidence and the mortality from the CVD. 
International postgraduate programmes have been developed on rural medicine. However, 
there are no special programmes on the CVD in rural medicine. In the developing and 
underdeveloped countries the larger part of the prevention and the PH are on the level of the 
rural medicine.
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Sub-modules 
Sub-module A
This sub-module is about prevention of the CVD in the rural environment. In the 
developing countries, there is a considerable reduction of the average life span, an increase 
of the infant death, and increased frequency of deaths assigned with “unknown cause”, which 
we do consider to be due to CVD. In those environments, the “prevention culture” is very 
low, and there is an “inertia” and “passiveness” in terms of prevention and management of 
the CVD, as well as other entities (26). 
Sub-module B
This sub-module is about evaluation of the level of CVD prevention and care in a given 
region: medical professionals, experience, technologies, transportation, awareness of the 
population, indicators or data on frequencies and mortality, awareness of the risk factors, and 
other indicators (life length, SES, family histories). 
Sub-module C
This sub-module is about how the situation in the country can be changed and 
improved: 
1. opportunities to improve the conditions in the country; 
2. opportunities to improve the communication with the advanced PH centres; 
3. opportunities of training the local medical staff on CVD prevention. 
Sub-module D
This sub-module is about information and health communication. Information providing 
is probably the most important instrument of CVD detection and prevention in the rural 
places and the developing countries. Some of the activities include: 
1. how to use the mass media, the modern technologies, and the direct contact for increasing 
the population awareness of the CVD; 
2. information in schools and in working places; 
3. organizing and training the local non-professionals and volunteers for the purpose of the 
effective health communication. 
Future science, technologies, optimization and information
This module is appropriate for health system planners, future private care providers, or 
in conjunction with the other modules. Development is going more rapidly than ever in both 
predictive and un-predictive directions (27-29). Why this module? In the CVD medicine, the 
rates of the changes are rapid enough to unable predictions even within a decade. The present 
expertise becomes “out of date” within such periods. The last few decades the CVD practice 
has evolved from physical examination to invasive procedures. The future of the CVD could 
be divided in the following four phases: 
1. present: dominantly clinical phase (high performance imaging technologies, combined 
with the interventional and cellular procedures); 
2. future: predominantly preventive phase (Human Genome Project as a basis for prevention, 
detection	and	treatment,	new	pharmacies	for	CVD	prevention,	aging	modifications	(29),	
environmental	 and	 psychological	modifications,	 prevention	market	modifications,	 and	
general PH transformations. 
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Predictions of those and other innovations are the key to the “survival” of the future PH and 
medical practitioners. 
Concluding remarks
1. The CVD are considered the most important subject in the present public health 
spectrum, since occupying the highest position in terms of the epidemiological 
indicators including mortality, morbidity, disability, and overall costs. 
2. The tremendous success of the clinical management of the CVD and the medicine in 
general resulted in “three nonlinear functions”: increase of lifespan, increase of the 
population, and increase of the health-related costs. There is also an evident increase 
of the awareness about the CVD, but it is still bellow the “critical point” of what is 
needed for collective self-control of the occurrence and the consequences. 
3. The impact of the tremendous increase of the costs results in the social status related 
reduced accessibility to preventive and treatment facilities, disparity of the possibilities 
of performance and the possibilities of provision, and eventually the divergence of the 
incidence of the disease and the requirements for proper prevention and follow up. 
4. The prevention, although theoretically well conceptualized, resides still at the bottom 
of	the	expected	level.	The	social	and	the	financial	aspects	remain	a	good	rhetoric,	with	
a pronounced lack of action. 
5. The ten modules capture the framework of the public health problem, some of them 
being at the “embryonic” phase of development, requiring thorough engagement of 
the professionals, the students and the whole population. 
6. We stress the importance of the “home medicine” and the information providing as 
fundamental instruments of the future PH and management of the CVD. The basic 
principles of the strategies for CVD management and prevention as monitored by the 
PH institutions should consist of the following: 
•	 population health; 
•	 effective CVD services; 
•	 evidence based decision making; 
•	 community participation; 
•	 health-oriented public policy; 
•	 holistic approach; 
•	 multilevel information diffusion. 
Exercise
Epidemiology of CVD
Task 1:
Which are the mortality rates of the CVD in your country? Do you know the prevalence 
and the incidence rates of MI and ACS in your country? Which are the epidemiological data 
on stroke in your place? Which are the prevalence rates of diabetes, hypertension, and other 
risk factors? What can you do to improve data collection related to CVD in your country? 
How long is the average life in your population (why)? In which phase of epidemiological 
transition is your country?
Task 2:
Make	a	small	terrain	study,	with	the	help	of	the	mentor.	This	represents	a	rather	difficult	task,	
since	it	reveals	the	real	difficulties	of	data	collection,	which	are	related	to	the	following:	
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•	 poor registration and administration in the rural and developing regions (including 
some quarters in the world metropolises), 
•	 absent motivation for such research in the remote places and the private medical 
institutions, 
•	 insufficiency	of	relevant	cadres,	and	
•	 poor “epidemiological and PH culture” in that region. 
Consider an elaborate of how are you going to overcome those problems in your 
country?
Task 3:
Join an international group. Some enthusiasts have managed to contact with world 
authorities and institutions in data exchange, information exchange, participation on 
international conferences and congresses, and even obtaining research grants. Ideally, that 
would be a task of the PHS network, but individual initiatives are mostly valuable. 
Task 4:
When will you perform a screening: blood cholesterol, glycemia, blood pressure, ECG and 
neurological screening? 
Socioeconomic aspects of CVD public health
Task 1:
The student should perform research on the possible data and the articles on the CVD 
related to the SES in his/her country. 
Task 2:
He/she	should	become	acquainted	with	the	quantifiers	and	the	formulas	related	to	the	SES	
as presented by Regidor and other authors.
Task 3:
Find the parameters of the socioeconomic status of your country (as listed by the World 
Bank, IMF and CIA which can be fount on the Internet). 
Task 4:
Learn about the Lorenz curve, and the Gini index and the income inequality indices. 
Task 5:
Make a plan how to collect data related to the SES in your country. How do you plan 
to improve the status of your population? How will you make a plan for a strategy on the 
improvement of the social and economic performances in your country as mirrored by the 
CVD indicators?
Task 6:
How will you be able to activate the political and the public opinion about the weakness 
of the social system in your country using data related to the CVD?
Task 7:
Take the individual and the collective interests, think of the superposition theory, game 
theory, and the competitiveness development. 
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Task 8:
Hospitals are and will be “sociological monads” in the future. Lemma: social health 
inequalities (H) are mappings of the general social inequalities (G): H -> G. Therefore 
interventions on H imply interventions on G. Make your own thought experiments considering 
improvements in social medical inequalities, with parameters of the CVD (please look at the 
papers of Margaret Whitehead and the related papers (10-12). 
Task 9:
The	 task	 is	 on	 cost-benefit,	 cost-effectiveness	 and	 cost-utility	 analysis	 (CBA,	 CEA,	
CUA).	We	always	have	some	benefits	 (B)	 from	 the	health	prevention	and	 the	health	care	
actions,	which	can	be	calculated.	Those	benefits	require	investments	which	means	they	cause	
some costs (C). From economical point of view (B – C) > 0 is an approvable action. However 
sometimes	actions	are	undertaken	despite	the	equation	being	<	0.	In	that	case,	the	benefits	are	
greater than they can be estimated with economical indicators only. Perform a CBA for the 
prevention of the coronary heart disease and stroke from the data in your country. Is there a 
difference?	Are	the	interventions	on	the	same	risk	factors	giving	the	same	benefits	in	different	
entities (differential risk factor CBA)?
Financing the CVD related prevention and public health
Task 1:
The student should investigate the advantages and the disadvantages of the various 
compulsory health insurance systems and the universal health care. The oldest systems are 
in France, Italy, then Australia, Norway, Ireland and Canada. How much prevention is being 
considered? Which proportion of the compulsory health insurance would you consider for 
prevention of the CVD and/or general? How would you design a compulsory CVD prevention 
insurance programme? 
Task 2:
The student should become acquainted with some compulsory systems i.e. AMA (American 
Medical Association) compulsory health insurance programme, or the Massachusetts 
programme. There is a dichotomy between the just and the possible. The needs for medical 
financing	are	increasing,	in	particular	for	the	CVD,	while	the	resources	are	limited.	
Task 3:
Which	are	the	other	possible	(non-insurance)	sources	of	financing	the	PH	of	the	CVD?
Task 4:
Design	your	own	“ideal”	system	of	financing	the	CVD	prevention.	
Home prevention medicine
Task 1:
Think of the creativeness in the design of “home hospitals” (architectural, art-like, 
game-like, tourism-like, or economy). There are some examples of famous personalities on 
complex home treatments, yet building an “institution” of intellectual work in their home (i.e. 
Steven Hawking or Howard Hughes). Make a research and short case studies of examples 
you choose. 
Task 2:
How can nurses and the family take part in the home prevention?
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Information and health communication
Task1:
Write a report for a popular journal, on a CVD problem. Prepare (or simulate) a popular 
TV show on CVD. Develop methods to draw the attention of the population on the problem 
of the CVD pandemic.
Task 2:
Propose new innovative models of information spreading (apart from the TV and 
journalism) i.e.: toys, mobile phones, internet, posters, camps etc. Focus your efforts more 
on the psychology, rather than the technology.
Rural medicine and CVD prevention
Task 1:
Visit a rural place with a good CVD practice. Visit a place with a poor CVD practice. 
Write a report. 
Task 2:
Give some examples (case studies) of a good rural PH on CVD.
Future of the CVD prevention and the PH
Task 1:
Discussions and elaborates on the future technological developments: novel biomaterials, 
markers,	 artificial	 organs,	 proteomics,	 genomic	 therapies,	 the	 Human	 Genome	 Project,	
cellular treatments, molecular imaging, multidimensional imaging, robotic surgeries, stem 
cell and progenitor cell technologies, chromosomal surgeries, embryonic surgeries and 
genomic therapies, etc and how they can be used in prevention. 
Task 2:
There	are	few	serious	and	very	exciting	research	projects	going	on	in	the	field	of	aging	
(29). Although in the last century the average life almost has doubled, it would be not 
appropriate in the present time position to discuss about the possibilities of the future aging 
treatments. From the social medicine aspect, it would be most appropriate for this generation 
to prepare for the forthcoming “old age wave” with programmes for decent housing, “home 
medicine”, activities, and most of all – programmes for becoming realistically useful in the 
group and the society. Achieving recognition of the high values and the wisdom of the aged 
people	will	be	a	revolution.	Make	your	(fictive)	programme	of	integrating	old	people	and	the	
handicapped in the society and the economics. 
Task 3:
Future institutional and home therapy models: modern mobile units, home-monitoring 
and telecommunication systems, future home nursing, self-diagnosis, automated diagnosis, 
and self-management procedures, complex-care systems kits, home care kits, “home-micro-
hospitals”, novel constructions and architectures, novel patient-doctor associations, novel 
models of companies and trusts. Contribute with new ideas to this short list. 
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Task 4:
Develop a CVD surveillance system for providing data on an ongoing basis in your 
country and on the global scale. That will provide the possibility of monitoring, evaluating 
the quality of service, the introduction and appropriate use of the recent discoveries in the 
area, upgrade the clinical and prevention guidelines, and evaluate the econometric parameters 
related to the CVD. 
Task 5:
Discuss the future educational and information models: home learning and tuition, 
telecommunication information about the status of the CVD spread and the supervision of 
CVD patients (“telecommunication clinics”), online permanent information systems, visual 
facilities, new propaganda break-through, new school programmes, new feed-back models of 
education and treatment supervision.
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